Premium
The COVID‐19 pandemic and reproductive genetic counseling: Changes in access and service delivery at an academic medical center in the United States
Author(s) -
Mann Caitlin,
Goodhue Brighton,
Guillard Arianna,
Slamon Jill,
Newman Randa,
Zhao Zhiguo,
Ding Tan,
Petrelli Gianna,
Dudek Martha
Publication year - 2021
Publication title -
journal of genetic counseling
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.867
H-Index - 52
eISSN - 1573-3599
pISSN - 1059-7700
DOI - 10.1002/jgc4.1462
Subject(s) - telehealth , genetic counseling , medicine , pandemic , telemedicine , family medicine , demographics , covid-19 , health care , disease , demography , biology , infectious disease (medical specialty) , economics , genetics , economic growth , sociology
Abstract The COVID‐19 pandemic widely disrupted the delivery of healthcare services, including genetic counseling. To ensure continuity of care, the reproductive genetic counselors at a large academic medical center in the United States rapidly transitioned their practice from 90% in‐person patient consultations to a predominantly telehealth model. The present study describes this transition in regard to patient access to genetic counseling and genetic screening. A chart review of patients seen by the reproductive genetic counselors from January 2020 to August 2020 was completed. The time frame included the three months prior to the COVID‐19 pandemic and the first five months during COVID‐19. Patient demographics and clinical and appointment data were compared between the pre‐COVID‐19 and during‐COVID‐19 timeframes. Overall, 88.6% of patients were seen via telehealth during COVID‐19 and there was no significant difference based upon patient age ( p = .20), indication for appointment ( p = .06), or gestational age ( p = .06). However, non‐English speaking patients were more often seen in‐person than by telehealth ( p < .001), and more patients residing farther from the clinic were seen via telehealth ( p = .004). During‐COVID‐19 results for prenatal cell‐free DNA screening and expanded carrier screening were delayed ( p < .001). Additionally, after consenting to screening, patients seen during COVID‐19 were more likely to not complete a sample collection for their intended screening when compared to those seen pre‐COVID‐19 (OR = 6.15, 95% CI = 1.43–26.70, p = .015). Overall, this study supports that access to genetic counseling services and genetic screening can be maintained during a global pandemic like COVID‐19. Genetic counselors are well‐equipped to pivot swiftly during challenging times; however, they must continue to work to address other barriers to accessing genetic services, especially for non‐English speaking populations. Future studies are needed to pose solutions to the obstacles confronted in this service delivery model during a global pandemic.